Nádia Armelin is a chemical engineer with a strong background in digital innovation and leadership. Since 2019, she has been a partner at Aggir Ventures Health, managing a healthcare-focused venture capital fund investing in Brazilian companies. A Six Sigma Black Belt, Edmund Hillary Fellow, and Harvard Business School GMP alumna, Nadia combines expertise in technology, healthcare, and business management.

Investor Profile

Based In: Rio de Janeiro, Brazil

Board Positions: Upflux, Salu, Medway, Nefroclinicas, Agora Consulta, Cienty, Deepful

Investor Type: VC Firm

Preferred Sector(s): Healthcare

Preferred Stage(s): Early and mid-stage healthcare companies

Preferred Geo(s): Brazil, Latin America

Website: https://aggirventures.com.br/

LAVCA Honors

Top Women Investors in Latin America 2024, 2025